Implementation of the global risk analysis in pulsed-dose rate brachytherapy: Methods and results

被引:2
|
作者
Mazeron, R. [1 ]
Aguini, N. [2 ]
del Campo, E. Rivin [1 ]
Dumas, I. [3 ]
Gensse, M. -C. [1 ]
Brusadin, G. [1 ]
Lefkopoulos, D. [3 ]
Deutsch, E. [1 ]
Haie-Meder, C. [1 ]
机构
[1] Gustave Roussy Canc Campus Grand Paris, Radiat Oncol, F-97805 Villejuif, France
[2] Gustave Roussy Canc Campus Grand Paris, Qual & Risk Assessment, F-97805 Villejuif, France
[3] Gustave Roussy Canc Campus Grand Paris, Med Phys, F-97805 Villejuif, France
来源
CANCER RADIOTHERAPIE | 2015年 / 19卷 / 02期
关键词
Pulsed-dose rate brachytherapy; Safety; Risk assessment; Global risk analysis; Mapping; RADIATION-THERAPY; FAILURE MODE; RADIOTHERAPY; TECHNOLOGIES; SAFETY; SYSTEM; CARE;
D O I
10.1016/j.canrad.2014.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. - To report the application of the global risk analysis (GRA) in the pulsed-dose rate (PDR) brachytherapy workflow. Material and Methods. - Analyses were led by a multidisciplinary working group established within the unit with the guidance of a quality engineer. First, a mapping of hazardous situations was developed as a result of interactions between the patient workflow for a treatment using PDR brachytherapy split into 51 sub-phases with a comprehensive list of the hazards that he/she faces (44). Interactions, when relevant, were sorted by level of priority: to be treated immediately, secondarily (the group is not entitled to treat the situation), or later (safe situation). Secondly, for each high priority dangerous situation, scenarios were developed to anticipate their potential consequences. Criticality was assessed, using likelihood and severity scales and a matrix, which allocated risks into categories: acceptable (C1), tolerable under control (C2) and unacceptable (C3). Then, corrective actions were proposed and planned when relevant, after assessment of their feasibility with a scale of effort. Finally, the criticality of the scenarios was reevaluated, taking into account the implementation of these actions, leading to a residual risk mapping, which could trigger additional proposals of actions. Results. - Two thousand one hundred and eighty-four potential interactions between the list of hazards and the workflow were analyzed. Mapping of dangerous situations identified 213 relevant interactions, from which 61 were considered with high priority. One hundred and twenty-six scenarios were generated: 68 with a low criticality (74.3%), 58 with an intermediate score (25.7%). No scenario with the highest criticality was individualized. Twenty-one corrective actions were planned. Mapping of residual risk resulted in the disappearance of most C2 risks, leaving 5 C2 scenarios (4%), for which four monitoring indicators were implemented in addition to the corrected actions decided on. Conclusion. - The implementation of the GRA appeared feasible, and led to implement 21 corrective actions, based on scenarios and not on incidents. (C) 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 50 条
  • [21] Pulsed dose rate (PDR) brachytherapy of anal carcinoma
    Roed, H
    Engelholm, SA
    Svendsen, LB
    Rosendal, F
    Olsen, KJ
    RADIOTHERAPY AND ONCOLOGY, 1996, 41 (02) : 131 - 134
  • [22] Technical feasibility of pulsed-dose-rate brachytherapy
    Skowronek, J
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S59 - S59
  • [23] Pulsed low dose rate brachytherapy for pelvic malignancies
    Swift, PS
    Purser, P
    Roberts, LW
    Pickett, B
    Powell, CB
    Phillips, TL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04): : 811 - 817
  • [24] Feasibility and tolerance of pulsed dose rate interstitial brachytherapy
    de Pree, C
    Popowski, Y
    Weber, D
    Nouet, P
    Rouzaud, M
    Kurtz, JM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (05): : 971 - 976
  • [25] From continuous low dose rate to pulsed dose rate brachytherapy: the practical benefits
    Koedooder, K
    Blank, L
    van der Grient, H
    Pieters, B
    Kipp, B
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S57 - S57
  • [26] Pulsed-Dose-Rate Intracavitary Brachytherapy in Cervical Carcinoma: Long-term Results
    Kumar, P.
    Sharma, D. N.
    Gandhi, A. K.
    Giridhar, P.
    Rath, G. K.
    Kumar, S.
    Gupta, S.
    Pandey, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E277 - E277
  • [27] Pulsed Dose Rate Brachytherapy of Lip Carcinoma: Clinical Outcome and Quality of Life Analysis
    El Ayachy, Radouane
    Sun, Roger
    Ka, Kanta
    Laville, Adrien
    Duhamel, Anne-Sophie
    Tailleur, Anne
    Dumas, Isabelle
    Bockel, Sophie
    Espenel, Sophie
    Blanchard, Pierre
    Tao, Yungan
    Temam, Stephane
    Moya-Plana, Antoine
    Haie-Meder, Christine
    Chargari, Cyrus
    CANCERS, 2021, 13 (06) : 1 - 13
  • [28] Pulsed dose rate (PDR) brachytherapy of anal carcinoma - Comment
    Peiffert, D
    RADIOTHERAPY AND ONCOLOGY, 1997, 44 (03) : 296 - 297
  • [29] Pulsed dose rate brachytherapy in the treatment of head and neck carcinoma
    Pokrajac, B
    Knocke, TH
    Fellner, C
    Seitz, W
    Schmid, R
    Pötter, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S96 - S96
  • [30] Physics and quality assurance for brachytherapy .2. Low dose rate and pulsed dose rate
    Williamson, JF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 124 - 124